HTLV-1 infection and health outcomes

Affiliations

¹ Internal Medicine Department, General University Hospital of Alicante, Alicante, Spain; Infectious Disease Unit, Miguel Hernandez University, Elche, Spain.
² Laboratory of Internal Medicine, Puerta de Hierro Research Institute, Madrid, Spain; Internal Medicine Department, Puerta de Hierro University Hospital, Madrid Spain; Microbiology Department, San Pablo-CEU University, Madrid, Spain.
³ UNIR Health Sciences School and Medical Center, Madrid 28040, Spain. Electronic address: vicente.soriano@unir.net.

Comment

José-Manuel Ramos et al. Lancet Infect Dis. 2020 Apr.

. 2020 Apr;20(4):407-408.

doi: 10.1016/S1473-3099(20)30133-X.

¹ Internal Medicine Department, General University Hospital of Alicante, Alicante, Spain; Infectious Disease Unit, Miguel Hernandez University, Elche, Spain.
² Laboratory of Internal Medicine, Puerta de Hierro Research Institute, Madrid, Spain; Internal Medicine Department, Puerta de Hierro University Hospital, Madrid Spain; Microbiology Department, San Pablo-CEU University, Madrid, Spain.
³ UNIR Health Sciences School and Medical Center, Madrid 28040, Spain. Electronic address: vicente.soriano@unir.net.

No abstract available

Comment on

Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies.
Schierhout G, McGregor S, Gessain A, Einsiedel L, Martinello M, Kaldor J. Schierhout G, et al. Lancet Infect Dis. 2020 Jan;20(1):133-143. doi: 10.1016/S1473-3099(19)30402-5. Epub 2019 Oct 21. Lancet Infect Dis. 2020. PMID: 31648940